about
Melatonin, a promising role in taxane-related neuropathy.Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer.Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors.Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trialsPeripheral neuropathy in cancer patients.Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational studyNeurotoxicity of taxanes: symptoms and quality of life assessment.A Case of Docetaxel Induced Myositis and Review of the Literature.Proposed medications for taxane-induced myalgia and arthralgia (Review).Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusionPeripheral neuropathy induced by paclitaxel: recent insights and future perspectives.Assessment of neuropathic pain in cancer patients.Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot StudyChemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.Emerging trends in understanding chemotherapy-induced peripheral neuropathy.Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases.Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of antimitotic agents.Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.Taxane-Induced Peripheral Neurotoxicity.Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors.Oxaliplatin induces muscle loss and muscle-specific molecular changes in MICE.Motor dominant neuropathy induced by adjuvant therapy with adriamycin and cyclophosphamide followed by dose-dense paclitaxel in a breast cancer patient.Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.
P2860
Q33903971-97BF7BF9-883D-41A0-8696-234E4F0DF549Q33916040-05F2447D-70B7-4C2B-A38A-4ECC42AC8876Q33989037-93292B09-A253-45DD-A978-8E5D8CBDD316Q34180965-8DC7B1A7-F704-4784-812E-D333861E429FQ34280846-EC9DA7FB-4893-4BD3-BA56-5D0826B7C294Q34633385-C59DEA58-5DAA-46C9-9764-8451564EABA8Q34843961-F546EE3A-5411-423A-B2FC-53B200D8979AQ35626798-CC89F718-0884-44B0-8B14-26A0F33A98B3Q35901470-449FE682-D4F4-4D86-8B41-B473C12C12D7Q36084331-5A0D5A45-E036-487C-A067-5E2216D79438Q36344699-3FE48C2F-0E01-4533-BFB8-87313A1E7D18Q36635810-23346960-3397-429E-A376-44CA432E37A5Q36726598-F7D8BB76-8971-40B5-8EC1-29CBF37B4280Q37544928-16CE18F9-3FD8-43E3-93D6-2BF32521AA79Q37574855-CF00492D-5FB2-4C06-B662-FCFB50380960Q37826427-65CC8A3A-BA68-4967-BD41-F4FDD1F3DB24Q37910812-4758CAE2-7D9D-496D-8AAC-D67176D68DFAQ38133440-70C69FEF-6C96-4F2C-B142-EE9CBB033911Q38999750-444C4CB0-14DA-44BC-BD77-8749C1D7953BQ39793470-D4E7C51B-3D98-4BB5-A29A-E6416F757239Q40605226-DAA7B3FE-E1E8-4D01-92B5-170DA2E0434FQ41346602-24C9C287-D36D-4F9C-845B-7C7FCA86AC8CQ45759415-B634EE54-4D3C-40E8-8F67-DF2C6CA33F37Q46031139-97337FEB-59D5-4355-A334-86A6D22C3903Q47841514-372B6340-3220-433D-A8C4-FAB07A8B6910Q50723373-F53C60BF-180E-4405-BBDD-E3EC92C46CE6Q51483995-EC3D60F8-2D74-4206-BF5D-BE188B1710A6Q55411583-1FB8AC89-EF2C-4315-8D1B-8F22D2DE2D05
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Motor neuropathy due to docetaxel and paclitaxel.
@en
Motor neuropathy due to docetaxel and paclitaxel.
@nl
type
label
Motor neuropathy due to docetaxel and paclitaxel.
@en
Motor neuropathy due to docetaxel and paclitaxel.
@nl
prefLabel
Motor neuropathy due to docetaxel and paclitaxel.
@en
Motor neuropathy due to docetaxel and paclitaxel.
@nl
P2093
P356
P1433
P1476
Motor neuropathy due to docetaxel and paclitaxel.
@en
P2093
A D Seidman
C Balmaceda
L M DeAngelis
R J Freilich
P304
P356
10.1212/WNL.47.1.115
P407
P577
1996-07-01T00:00:00Z